Literature DB >> 32866016

Unravelling the Enzymatic Degradation Mechanism of Supramolecular Peptide Nanofibers and Its Correlation with Their Internal Viscosity.

Yejiao Shi1, Peter A Summers2, Marina K Kuimova2, Helena S Azevedo1.   

Abstract

Enzyme-responsive supramolecular peptide biomaterials have attracted growing interest for disease diagnostics and treatments. However, it remains unclear whether enzymes target the peptide assemblies or dissociated peptide monomers. To gain further insight into the degradation mechanism of supramolecular peptide amphiphile (PA) nanofibers, cathepsin B with both exopeptidase and endopeptidase activities was exploited here for degradation studies. Hydrolysis was found to occur directly on the PA nanofibers as only surface amino acid residues were cleaved. The number of cleaved residues and the degradation efficiency was observed to be negatively correlated with the internal viscosity of the PA nanofibers, quantified to be between 200-800 cP (liquid phase) using fluorescence lifetime imaging microscopy combined with an environmentally sensitive molecular rotor, BODIPY-C10. These findings enhance our understanding on the enzymatic degradation of supramolecular PA nanofibers and have important implications for the development of PA probes for the real-time monitoring of disease-related enzymes.

Entities:  

Keywords:  cathepsin B; enzymatic degradation; fluorescence lifetime imaging; internal viscosity; molecular rotors; peptide nanofibers

Mesh:

Substances:

Year:  2020        PMID: 32866016     DOI: 10.1021/acs.nanolett.0c02781

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  2 in total

Review 1.  Bioresponsive Polymers for Nanomedicine-Expectations and Reality!

Authors:  Sabina Quader; Joachim F R Van Guyse
Journal:  Polymers (Basel)       Date:  2022-09-03       Impact factor: 4.967

2.  An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer.

Authors:  Yanan Sun; Bochen Lyu; Chang Yang; Bing He; Hua Zhang; Xueqing Wang; Qiang Zhang; Wenbing Dai
Journal:  Bioact Mater       Date:  2022-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.